礼来公司的口服GLP-1受体激动剂奥格列酮在两项成功的III期临床试验中展现出卓越的血糖控制效果，再次证实其作为2型糖尿病基础治疗方案的潜力。 – investor.lilly.com
Lilly”s oral GLP-1, orforglipron, demonstrated superior glycemic control in two successful Phase 3 trials, reconfirming its potential as a foundational treatment in type 2 diabetes (news.google.com) 02:21 #investor.lilly.com
Top Research Reports for UBS, Newmont & McKesson
Wednesday, October 15, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 16 major stocks, including UBS Group AG (UBS), Newmont Corp. (NEM) and McKesson Corp. (MCK), as well as a micro-cap stock The Cato Corp. (CATO). The Zacks microcap research is […]
Non-insulin ultra-simple nanogels stimulate GLP-1 secretion through TGR5 for oral diabetes treatment
Publication date: 15 November 2025 Source: Chemical Engineering Journal, Volume 524 Author(s): Yuhong Ma, Mujiao He, Zhen Yuan, Dechun Huang, Hongliang Qian
Lilly’s oral GLP-1, orforglipron, demonstrated superior glycemic control in two successful Phase 3 trials, reconfirming its potential as a foundational treatment in type 2 diabetes – investor.lilly.com
Lilly’s oral GLP-1, orforglipron, demonstrated superior glycemic control in two successful Phase 3 trials, reconfirming its potential as a foundational treatment in type 2 diabetes investor.lilly.com Lilly’s weight-loss pill shows better blood sugar control in late-stage trials Reuters Eli Lilly’s orforglipron bests Farxiga, padding oral GLP-1 case with pair of phase 3 diabetes wins Fierce Biotech Lilly’s orforglipron […]
Melrose Place vet Jillian Barberie battled cancer and addiction, see what she looks like at 59 after losing 60lbs from GLP-1
The 59-year-old star – who was on NFL Sports Sunday – shared the news on her Instagram page on Wednesday. She decided to focus on her body after several years of medical struggles
GLP-1 medications found to slow alcohol absorption and lessen intoxication
There’s mounting evidence that popular drugs prescribed for diabetes management and weight loss – better known by trade names like Ozempic and Wegovy – could be effective in reducing alcohol use.
Madison Reed’s Bold Next Chapter: Agentic AI, Sticky Subscriptions & Poised For Possible IPO
Madison Reed isn’t just selling hair color—it’s building an AI-driven retail engine with GLP-1-level stickiness and Wall Street ambitions.
Unsupervised Learning NO. 502
UPDATES Hey! Hope you all are doing well! — Found a really cool California Wastewater dataset that tracks COVID and Flu numbers. I’ve integrated it into Kai as well so now I can just ask and he’ll go get the latest data. THE DATA AND DASHBOARD Kai’s Result of the /check-california-wastewater-status command — About to […]
GLP-1 food boom: Market growth, big brands, and key challenges
The GLP-1 food market is booming, with global value hitting $53bn and major brands like Nestlé and General Mills launching GLP-1-friendly products. Driven by rising medication use and shifting consumer habits, the trend is reshaping innovation across snacks, meals and desserts. However, regulatory risks, uneven adoption and production costs pose challenges for manufacturers.
Lilly’s oral GLP-1 racks up two more clinical wins in diabetes
Eli Lilly’s GLP-1 pill has succeeded in two more late-stage trials in type 2 diabetes. The company said Wednesday that orforglipron beat AstraZeneca’s Farxiga at lowering patients’ blood sugar levels in …